Standard DAPT is named as an intervention in 2 current clinical trials in our China and South Korea registers. 2 are recruiting patients now. All registered phases are Not applicable. The sponsor with the most trials is Shenyang Northern Hospital (1). The most-studied condition is Acute Coronary Syndrome.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time
NCT06216821 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome
|
Not applicable | Recruiting | Shenyang Northern Hospital | China |
|
OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
NCT07198529 · ClinicalTrials.gov ↗ · Stable Angina, Coronary Artery Disease
|
Not applicable | Recruiting | Korea University Guro Hospital | South Korea |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Shenyang Northern Hospital | 1 |
| Korea University Guro Hospital | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 1 | 1 |
| Clinical trials in South Korea | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our China and South Korea registers name Standard DAPT as a drug or biological intervention, as of the registry sync on 28 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 1 with sites in China and 1 with sites in South Korea. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Shenyang Northern Hospital (1) and Korea University Guro Hospital (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Standard DAPT works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Standard DAPT works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Standard DAPT (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 28 Sep 2026.